FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767353242> ?p ?o ?g. }

• W2767353242 endingPage "218" @default.
• W2767353242 startingPage "211" @default.
• W2767353242 abstract "Preeclampsia risk is influenced by both the mother’s genetic background and the genetics of her fetus; however, the specific genes responsible for conferring preeclampsia risk have largely remained elusive. Evidence that preeclampsia has a genetic predisposition was first detailed in the early 1960s, and overall preeclampsia heritability is estimated at ∼55%. Many traditional gene discovery approaches have been used to investigate the specific genes that contribute to preeclampsia risk, but these have largely not been successful or reproducible. Over the past decade, genome-wide association studies have allowed for significant advances in the understanding of the genetic basis of many common diseases. Genome-wide association studies are predicated on the idea that the genetic basis of many common diseases are complex and polygenic with many variants, each with modest effects that contribute to disease risk. Using this approach in preeclampsia, a large genome-wide association study recently identified and replicated the first robust fetal genomic region associated with excess risk. A screen of >7 million genetic variants in 2658 offspring from preeclamptic women and 308,292 population controls identified a single association signal close to the Fms-like tyrosine kinase 1 gene, on chromosome 13. Fms-like tyrosine kinase 1 encodes soluble Fms-like tyrosine kinase 1, a splice variant of the vascular endothelial growth factor receptor that exerts antiangiogenic activity by inhibiting signaling of proangiogenic factors. The Fms-like tyrosine kinase 1 pathway is central in preeclampsia pathogenesis because excess circulating soluble Fms-like tyrosine kinase 1 in the maternal plasma leads to the hallmark clinical features of preeclampsia, including hypertension and proteinuria. The success of this landmark fetal preeclampsia genome-wide association study suggests that well-powered, larger maternal and fetal genome-wide association study will be fruitful in identifying additional common variants that implicate causal preeclampsia genes and pathways. Such efforts will rely on the continued development of large preeclampsia consortia focused on preeclampsia genetics to obtain adequate sample sizes, detailed clinical phenotyping, and matched maternal-fetal samples. In summary, the fetal preeclampsia genome-wide association study represents an exciting advance in preeclampsia biology, suggesting that dysregulation at the Fms-like tyrosine kinase 1 locus in the fetal genome (likely in the placenta) is a fundamental molecular defect in preeclampsia. Preeclampsia risk is influenced by both the mother’s genetic background and the genetics of her fetus; however, the specific genes responsible for conferring preeclampsia risk have largely remained elusive. Evidence that preeclampsia has a genetic predisposition was first detailed in the early 1960s, and overall preeclampsia heritability is estimated at ∼55%. Many traditional gene discovery approaches have been used to investigate the specific genes that contribute to preeclampsia risk, but these have largely not been successful or reproducible. Over the past decade, genome-wide association studies have allowed for significant advances in the understanding of the genetic basis of many common diseases. Genome-wide association studies are predicated on the idea that the genetic basis of many common diseases are complex and polygenic with many variants, each with modest effects that contribute to disease risk. Using this approach in preeclampsia, a large genome-wide association study recently identified and replicated the first robust fetal genomic region associated with excess risk. A screen of >7 million genetic variants in 2658 offspring from preeclamptic women and 308,292 population controls identified a single association signal close to the Fms-like tyrosine kinase 1 gene, on chromosome 13. Fms-like tyrosine kinase 1 encodes soluble Fms-like tyrosine kinase 1, a splice variant of the vascular endothelial growth factor receptor that exerts antiangiogenic activity by inhibiting signaling of proangiogenic factors. The Fms-like tyrosine kinase 1 pathway is central in preeclampsia pathogenesis because excess circulating soluble Fms-like tyrosine kinase 1 in the maternal plasma leads to the hallmark clinical features of preeclampsia, including hypertension and proteinuria. The success of this landmark fetal preeclampsia genome-wide association study suggests that well-powered, larger maternal and fetal genome-wide association study will be fruitful in identifying additional common variants that implicate causal preeclampsia genes and pathways. Such efforts will rely on the continued development of large preeclampsia consortia focused on preeclampsia genetics to obtain adequate sample sizes, detailed clinical phenotyping, and matched maternal-fetal samples. In summary, the fetal preeclampsia genome-wide association study represents an exciting advance in preeclampsia biology, suggesting that dysregulation at the Fms-like tyrosine kinase 1 locus in the fetal genome (likely in the placenta) is a fundamental molecular defect in preeclampsia." @default.
• W2767353242 created "2017-11-17" @default.
• W2767353242 creator A5030159705 @default.
• W2767353242 creator A5034035976 @default.
• W2767353242 creator A5048998630 @default.
• W2767353242 date "2018-02-01" @default.
• W2767353242 modified "2023-10-18" @default.
• W2767353242 title "Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis" @default.
• W2767353242 cites W1904831760 @default.
• W2767353242 cites W1947642372 @default.
• W2767353242 cites W1967129767 @default.
• W2767353242 cites W1969673534 @default.
• W2767353242 cites W1969689988 @default.
• W2767353242 cites W1972456226 @default.
• W2767353242 cites W1978940943 @default.
• W2767353242 cites W1985148126 @default.
• W2767353242 cites W1986818660 @default.
• W2767353242 cites W1989716723 @default.
• W2767353242 cites W1990795537 @default.
• W2767353242 cites W1992903011 @default.
• W2767353242 cites W2004577377 @default.
• W2767353242 cites W2004728877 @default.
• W2767353242 cites W2006245385 @default.
• W2767353242 cites W2009733568 @default.
• W2767353242 cites W2013376909 @default.
• W2767353242 cites W2014496401 @default.
• W2767353242 cites W2015382047 @default.
• W2767353242 cites W2017904618 @default.
• W2767353242 cites W2021964897 @default.
• W2767353242 cites W2023549854 @default.
• W2767353242 cites W2028131307 @default.
• W2767353242 cites W2029946027 @default.
• W2767353242 cites W2043135188 @default.
• W2767353242 cites W2047884439 @default.
• W2767353242 cites W2049983920 @default.
• W2767353242 cites W2056262625 @default.
• W2767353242 cites W2058008120 @default.
• W2767353242 cites W2065594976 @default.
• W2767353242 cites W2067808952 @default.
• W2767353242 cites W2078663610 @default.
• W2767353242 cites W2081966931 @default.
• W2767353242 cites W2084017024 @default.
• W2767353242 cites W2086863186 @default.
• W2767353242 cites W2087436149 @default.
• W2767353242 cites W2091107082 @default.
• W2767353242 cites W2091860804 @default.
• W2767353242 cites W2094395765 @default.
• W2767353242 cites W2097532741 @default.
• W2767353242 cites W2099463290 @default.
• W2767353242 cites W2104310850 @default.
• W2767353242 cites W2105019573 @default.
• W2767353242 cites W2112962699 @default.
• W2767353242 cites W2116609720 @default.
• W2767353242 cites W2129206669 @default.
• W2767353242 cites W2134502189 @default.
• W2767353242 cites W2140476817 @default.
• W2767353242 cites W2140763575 @default.
• W2767353242 cites W2140764146 @default.
• W2767353242 cites W2143122517 @default.
• W2767353242 cites W2143180984 @default.
• W2767353242 cites W2156016652 @default.
• W2767353242 cites W2159530790 @default.
• W2767353242 cites W2163404739 @default.
• W2767353242 cites W2169523654 @default.
• W2767353242 cites W2170353692 @default.
• W2767353242 cites W2233974801 @default.
• W2767353242 cites W2250497524 @default.
• W2767353242 cites W2285459301 @default.
• W2767353242 cites W2341980020 @default.
• W2767353242 cites W2470467076 @default.
• W2767353242 cites W2490125132 @default.
• W2767353242 cites W2702621018 @default.
• W2767353242 cites W2725988230 @default.
• W2767353242 cites W341951596 @default.
• W2767353242 cites W37710132 @default.
• W2767353242 cites W4251118184 @default.
• W2767353242 cites W4382916220 @default.
• W2767353242 doi "https://doi.org/10.1016/j.ajog.2017.11.562" @default.
• W2767353242 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5807126" @default.
• W2767353242 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29138037" @default.
• W2767353242 hasPublicationYear "2018" @default.
• W2767353242 type Work @default.
• W2767353242 sameAs 2767353242 @default.
• W2767353242 citedByCount "57" @default.
• W2767353242 countsByYear W27673532422018 @default.
• W2767353242 countsByYear W27673532422019 @default.
• W2767353242 countsByYear W27673532422020 @default.
• W2767353242 countsByYear W27673532422021 @default.
• W2767353242 countsByYear W27673532422022 @default.
• W2767353242 countsByYear W27673532422023 @default.
• W2767353242 crossrefType "journal-article" @default.
• W2767353242 hasAuthorship W2767353242A5030159705 @default.
• W2767353242 hasAuthorship W2767353242A5034035976 @default.
• W2767353242 hasAuthorship W2767353242A5048998630 @default.
• W2767353242 hasBestOaLocation W27673532422 @default.
• W2767353242 hasConcept C101544691 @default.
• W2767353242 hasConcept C104317684 @default.
• W2767353242 hasConcept C106208931 @default.

• next